Jeff Galvin Presents at ARM’s 7th Annual Cell & Gene Therapy Investor Day

CEO Jeff Galvin presents at Alliance for Regenerative Medicine (ARM)’s 7th Annual Cell & Gene Therapy Investor Day
CEO Jeff Galvin presents at Alliance for Regenerative Medicine (ARM)’s 7th Annual Cell & Gene Therapy Investor Day
Subscribe to our YouTube Channel

CEO Jeff Galvin presents at Alliance for Regenerative Medicine (ARM)’s 7th Annual Cell & Gene Therapy Investor Day. The event provides institutional, strategic and venture investors with unique insight into financing opportunities for cell and gene therapy-based treatment and tools.

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!